Treatment Advances and Evolving Standard of Care in Atopic Dermatitis - Episode 13
Data from LEVEL UP Trial with Upadacitnib in Atopic Dermatitis
Jonathan Silverberg, MD, PhD, MPH, reviews findings from the LEVEL UP study investigating upadacitinib in patients with moderate-to-severe atopic dermatitis.
Video content above is prompted by the following:
- Please discuss Level Up data with upadacitinib that were recently presented at RAD 2024.
- What are clinical implications of these data for everyday practice?
